Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action doi.org/10.1177/033310…

A systematic review and meta-analysis investigating the epidemiology and clinical features of short-lasting unilateral neuralgiform headache attacks. journals.sagepub.com/doi/10.1177/03… #headache #neurology #review

🎉 IHS Juniors Forum – Places Still Available! 🎉 Junior doctors, students, and trainees, join us for a FREE evening on Saturday, 7 September at Bounce Farringdon! Enjoy ping pong, Beer Pong, Karaoke, small bites, pizzas, and drinks. 🍕🍻🎤 If you're attending MTIS 2024 and

The 20th Migraine Trust International Symposium opening session starts! 🧠

Injection of OnabotulinumtoxinA towards the sphenopalatine ganglion is effective in refractory chronic migraine and chronic cluster headache and remains so after repeat injections. journals.sagepub.com/doi/10.1177/03… #headache #migraine #neurology

The Cephalalgia Editorial Board Meeting took place during #mtis2024, where a report was presented at the start, followed by discussions on future plans. We would greatly appreciate hearing your thoughts on how we can further improve the quality of the journal.

We are delighted to meet Charl Van Zyl, CEO of Lundbeck and Maria Alfaiate, Vice-pressent of Lundbeck. Thank you both! LundbeckUS

📢 IHS at MTIS! We're excited to be here! Come visit us in the Exhibition Hall 👋 #MTIS2024 #migraine #headache

Substantial burden was demonstrated across all 6 countries with over 30% of respondents experiencing anxiety and depression and over 40% reporting work impairment in the previous 7 days. journals.sagepub.com/doi/10.1177/03… #headache #migraine #neurology

Please visit the MTIS24 Registration Desk if you want to join us for the Junior’s Forum and have not registered your attendance online. The Junior’s Forum will be held on Saturday 7 September, please meet at the Registration Desk at 18.30 promptly to travel to the venue.

We are thrilled to connect BASH BASH at #MTIS and collaborate on ways to advance our shared mission to care for people with headache worldwide!

Our IHS leaders and committee members are proud to be participating in #MTIS2024. Let’s come together to advance headache care worldwide! 💡✨

This really important paper provides compelling evidence that early treatment with anti-CGRP monoclonal antibodies enhances response in the real world for migraine prevention bit.ly/3SxC6Nl

Al-Khazali et al. show that individuals with migraine experience more problems related to neck pain compared to those with tension-type headache and healthy individuals without headache. journals.sagepub.com/doi/10.1177/03… #headache #migraine

Do you know that IHC2025 will be held exactly one year from today in São Paulo? IHS President Rami Burstein has sent a warm invitation to the headache community worldwide to attend. #headache #congress #SãoPaulo

🎉Just one year away🎉 IHS President-elect Mario Peres invites you to IHC 2025, happening September 10-14, 2025, in São Paulo, Brazil. This will be the first-ever IHC in South America! Save the date and join us for this landmark event! #IHC2025 #headache

The GBD2021 study reveals migraine is one of the main neurological disorders, leading in DALYs, impacting 1.16 billion. Urgent public health action is needed to raise awareness, improve treatment, and advance research. journals.sagepub.com/doi/10.1177/03… #headache #migraine #neurology